Humacyte, Inc.·4

Dec 15, 7:53 PM ET

Scheessele William John 4

4 · Humacyte, Inc. · Filed Dec 15, 2022

Insider Transaction Report

Form 4
Period: 2022-12-13
Scheessele William John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-12-13$3.09/sh+5,000$15,45015,525 total

Documents

1 file
  • 4
    wf-form4_167115202101303.xmlPrimary

    FORM 4